Published in J Lipid Res on May 05, 2010
Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J Lipid Res (2011) 0.93
Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells. J Lipid Res (2012) 0.81
Lipidomics of glycosphingolipids. Metabolites (2012) 0.80
Bacteriophages as pathogens and immune modulators? MBio (2013) 0.77
A Rapid and Sensitive Method to Measure the Functional Activity of Shiga Toxins in Human Serum. Toxins (Basel) (2015) 0.75
Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment. J Lipid Res (2015) 0.75
A Topographical Atlas of Shiga Toxin 2e Receptor Distribution in the Tissues of Weaned Piglets. Toxins (Basel) (2016) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest (1955) 31.08
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet (2005) 9.78
Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun (1986) 8.09
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res (2004) 4.67
Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol (2005) 4.63
Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem (1989) 3.22
Gangliosides: structure, isolation, and analysis. Methods Enzymol (1982) 3.20
A glycolipid on the surface of mouse natural killer cells. Eur J Immunol (1980) 3.13
Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res (2008) 2.62
Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (1992) 2.49
Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry (1998) 2.38
The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli. J Med Microbiol (1971) 2.30
Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res (1971) 2.29
The challenge of lipid rafts. J Lipid Res (2008) 2.23
Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J Lipid Res (2008) 2.03
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
Role of verotoxin receptors in pathogenesis. Trends Microbiol (1996) 1.95
Furin-induced cleavage and activation of Shiga toxin. J Biol Chem (1995) 1.71
Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review. J Lipid Res (2008) 1.68
Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol (2009) 1.57
Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res (2001) 1.57
Shiga toxins. Toxicon (2001) 1.54
Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem (1991) 1.53
Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun (2001) 1.49
Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood (2001) 1.46
LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J Lipid Res (2006) 1.42
The role of glycosphingolipid metabolism in the developing brain. J Lipid Res (2008) 1.37
Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry (1988) 1.37
Characterization and direct quantitation of cerebroside molecular species from lipid extracts by shotgun lipidomics. J Lipid Res (2004) 1.37
Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem Rev (2006) 1.33
The physiological and molecular regulation of lipoprotein assembly and secretion. Mol Biosyst (2007) 1.30
HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J Biol Chem (2002) 1.28
Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography. J Lipid Res (1966) 1.26
Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR. J Lipid Res (2001) 1.22
Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol (1998) 1.21
Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol (2005) 1.21
Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res (2008) 1.19
The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell (2005) 1.15
Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J Biochem (1991) 1.12
Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res (2009) 1.11
Thin-layer chromatography of neutral glycosphingolipids. Methods Enzymol (1975) 1.09
Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J Lipid Res (1976) 1.09
Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb Haemost (2005) 1.09
Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost (2009) 1.07
Nuclear sphingolipids: metabolism and signaling. J Lipid Res (2008) 1.05
Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One (2009) 1.04
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS One (2009) 0.96
Glycosphingolipids as toxin receptors. Semin Cell Dev Biol (2004) 0.95
Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome. J Clin Microbiol (2006) 0.89
Intestinal lipoprotein synthesis and secretion. Prog Lipid Res (1995) 0.89
Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. Anal Chem (2004) 0.88
Interactions between Shiga toxins and human polymorphonuclear leukocytes. J Leukoc Biol (2008) 0.87
Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells. Glycobiology (1999) 0.87
Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues. J Infect Dis (2004) 0.86
Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom Rev (2010) 0.86
Structural characterization of gangliosides from murine T lymphocytes. Eur J Biochem (1987) 0.85
Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase. Glycobiology (2009) 0.85
Glycosphingolipids and plasma lipoproteins: a review. Can J Biochem Cell Biol (1984) 0.85
Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun Mass Spectrom (2005) 0.85
Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj J (2008) 0.84
3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J Lipid Res (2002) 0.82
Different distributions of glycosphingolipids in mouse and rabbit skeletal muscle demonstrated by biochemical and immunohistological analyses. J Biochem (1994) 0.82
Effect of serum on ganglioside uptake and choleragen responsiveness of transformed mouse fibroblasts. J Lipid Res (1978) 0.82
Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. Anal Chem (2008) 0.81
Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts. J Mass Spectrom (2007) 0.80
Glycosphingolipids of human plasma. Arch Biochem Biophys (1985) 0.80
Reversible exchange of glycosphingolipids between human high and low density lipoproteins. J Biol Chem (1982) 0.80
TLC in structure and recognition studies of glycosphingolipids. Methods Mol Biol (1998) 0.79
Isolation and structural characterization of glycosphingolipids of in vitro propagated bovine aortic endothelial cells. Glycobiology (1997) 0.78
Distribution of antithrombin III and glucosylceramide in human plasma lipoproteins and lipoprotein deficient plasma. Lipids (1984) 0.76
Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol (2006) 14.53
Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis (2011) 8.25
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med (2003) 7.78
Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One (2011) 6.75
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis (2001) 5.27
Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med (2010) 4.05
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol (2007) 3.80
Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol (2012) 3.75
Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med (2004) 3.17
Presence of mcr-1-positive Enterobacteriaceae in retail chicken meat but not in humans in the Netherlands since 2009. Euro Surveill (2016) 3.05
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood (2004) 2.95
Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis (2008) 2.92
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis (2002) 2.89
Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res (2009) 2.87
Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med (2006) 2.75
Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis (2006) 2.75
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood (2007) 2.64
Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis (2005) 2.50
Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol (2003) 2.36
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35
Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol (2003) 2.27
The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany. Dtsch Arztebl Int (2011) 2.11
Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol (2007) 2.07
Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun (2009) 1.93
Molecular phylogenetic analysis of uniovulate Euphorbiaceae (Euphorbiaceae sensu stricto) using plastid RBCL and TRNL-F DNA sequences. Am J Bot (2005) 1.92
A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc Natl Acad Sci U S A (2009) 1.87
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation (2002) 1.86
Shiga toxin-encoding bacteriophages--genomes in motion. Int J Med Microbiol (2004) 1.79
Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One (2007) 1.73
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother (2012) 1.62
Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model. Emerg Infect Dis (2007) 1.62
Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J Clin Microbiol (2002) 1.61
Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis (2004) 1.61
Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans. J Clin Microbiol (2002) 1.58
A new male sex pheromone and novel cuticular cues for chemical communication in Drosophila. Curr Biol (2009) 1.56
Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations. Infect Immun (2003) 1.55
Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR. Appl Environ Microbiol (2007) 1.55
Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int J Med Microbiol (2006) 1.53
Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. J Invest Dermatol (2011) 1.51
Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol (2011) 1.47
Atheroprotective effects of high-density lipoproteins. Annu Rev Med (2001) 1.46
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Clin Infect Dis (2013) 1.46
Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J Clin Microbiol (2003) 1.45
Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis (2013) 1.43
Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. Atherosclerosis (2013) 1.41
Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS One (2013) 1.41
Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol-fermenting Escherichia coli O157: H-. Int J Med Microbiol (2002) 1.40
Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol (2005) 1.37
Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J Clin Microbiol (2004) 1.37
Comparative molecular analysis substantiates zoonotic potential of equine methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2008) 1.36
Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J (2002) 1.36
Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl Environ Microbiol (2005) 1.33
Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis (2008) 1.32
Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun (2004) 1.31
Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol (2007) 1.31
Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol (2006) 1.30
Phenotypic and molecular analysis of tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting O157:NM clinical isolates. J Clin Microbiol (2005) 1.30
A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J Infect Dis (2002) 1.29
Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol (2009) 1.29
Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr Opin Immunol (2011) 1.28
Characterization of clonal relatedness among the natural population of Staphylococcus aureus strains by using spa sequence typing and the BURP (based upon repeat patterns) algorithm. J Clin Microbiol (2008) 1.26
Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods (2003) 1.25
Population dynamics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J Clin Microbiol (2012) 1.24
Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl Environ Microbiol (2005) 1.22
Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol (2014) 1.22
Human MRSA isolates with novel genetic homolog, Germany. Emerg Infect Dis (2012) 1.21
ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med (2011) 1.21
Methicillin-resistant Staphylococcus aureus (MRSA) isolated from small and exotic animals at a university hospital during routine microbiological examinations. Vet Microbiol (2007) 1.20
Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J Clin Microbiol (2009) 1.20
Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91. Emerg Infect Dis (2009) 1.18
Intrahost genome alterations in enterohemorrhagic Escherichia coli. Gastroenterology (2009) 1.17
Microbiological evaluation of a new growth-based approach for rapid detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2008) 1.16
Phylogeny, clinical associations, and diagnostic utility of the pilin subunit gene (sfpA) of sorbitol-fermenting, enterohemorrhagic Escherichia coli O157:H-. J Clin Microbiol (2004) 1.14
Molecular phylogenetics of Phyllanthaceae inferred from five genes (plastid atpB, matK, 3'ndhF, rbcL, and nuclear PHYC). Mol Phylogenet Evol (2005) 1.13
Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr Infect Dis J (2003) 1.13
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis (2012) 1.13
Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl Environ Microbiol (2007) 1.13
Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis (2007) 1.12
Nicotinamide increases systemic vascular resistance in ovine endotoxemia. Intensive Care Med (2003) 1.12
Transcription and enhancer profiling in human monocyte subsets. Blood (2014) 1.12
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol (2008) 1.11
Infection prevention in a connected world: the case for a regional approach. Int J Med Microbiol (2013) 1.11
Evidence for cost reduction based on pre-admission MRSA screening in general surgery. Int J Hyg Environ Health (2007) 1.11
Population structure of Staphylococcus aureus from remote African Babongo Pygmies. PLoS Negl Trop Dis (2011) 1.11
Molecular phylogenetic analysis of Phyllanthaceae (Phyllanthoideae pro parte, Euphorbiaceae sensu lato) using plastid RBCL DNA sequences. Am J Bot (2004) 1.11